chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was suffering from nasal congestion the whole spring of 2022 and thought it was allergies. I was diagnosed with ear infection in May. After this 3 family members tested positive for Covid and then I tested positive on June 5, 2022. The only symptom I had during quarantine was a stuffy nose. My entire family received the vaccines and the boosters and we still got the Omicron variant. The family had a runny nose but no fever or any other symptoms. My husband had runny nose and a bit of a cough.
Began around 8/31/21:  Lips dry, peeling and  burning with small papules around edge, with ulcers inside mouth.  Was present for a week, subsided, and is now beginning again.  No significant change in diet.  Took a 7 day course of doxycycline for a puncture wound  8/24/21-8/30/21.
got your vaccine and developed 2 heart conditions afterwards; nerve damage to his heart; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the parent.  A 27-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC DISORDER (hospitalization), outcome "unknown", described as "got your vaccine and developed 2 heart conditions afterwards"; NERVE INJURY (hospitalization), outcome "unknown", described as "nerve damage to his heart". The events "got your vaccine and developed 2 heart conditions afterwards" and "nerve damage to his heart" required physician office visit. Therapeutic measures were taken as a result of nerve injury.  Clinical course: Reporter stated, son age 27, got your vaccine and developed 2 heart conditions afterwards. He had been seen by doctors and even hospitalized since receiving the COVID shot some time ago. Most recently, he was prescribed a medication for nerve damage to his heart. Reporter would have an attorney reach out to your organization.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore arm after the first 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after the first 2nd dose) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Nephrectomy (one of his kidneys removed before getting any of the vaccines). Concurrent medical conditions included Renal cell carcinoma and Immunocompromised.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm after the first 2nd dose). At the time of the report, PAIN IN EXTREMITY (Sore arm after the first 2nd dose) outcome was unknown.   No concomitant drug was reported. No Treatment medications were reported.   This case was linked to MOD-2022-541251, MOD-2022-541259 (Patient Link).
Sweating; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating) and CHILLS (chills) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TREPROSTINIL SODIUM (REMODULIN) injection for Pulmonary arterial hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included MACITENTAN (OPSUMIT) for an unknown indication.   On 07-Jun-2021, the patient started TREPROSTINIL SODIUM (REMODULIN) (Intravenous) .047. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced HYPERHIDROSIS (Sweating) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (Sweating) and CHILLS (chills) outcome was unknown.            Treatment details were not provided.
sores on tongue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of GLOSSODYNIA (sores on tongue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GLOSSODYNIA (sores on tongue). At the time of the report, GLOSSODYNIA (sores on tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Arm pain for 4 days Tiredness for 3 days Nausea for 2 days Extreme cramps on my period so much so I couldn?t get out of bed for 2 days, this does not ever happen to me. It started on 8/17/21
Patient tested positive for COVID 19 on 12/30/2021, admitted to hospital on 01/11/2022 for SOB.  Patient expired on 02/28/2022
12 hrs after vaccine administered, developed erythema, induration, heat, tenderness in (L) deltoid at site.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of oral, ROTATEQ lot # K010221, K011663, K016313 and lot # reported as K015816 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the medical assistant on 02-JUL-2015 concerning a patient of an unknown age and gender who on 23-JUN-2015 was vaccinated with a dose of oral, ROTATEQ (lot # K016313) (dose and route not reported) that was 87 hours temperature excursion. This lot was received on 08-APR-2015. This is one of several reports received from the same source. Additional information is not expected as all correspondence was received.
GBS; This is a spontaneous report from a non-contactable consumer via a Pfizer-sponsored program  Support. This consumer reported similar events for six patients. This is the third of six reports. This patient of unspecified age and gender received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not provided. On unspecified date, the patient developed GBS (Guillain-Barre syndrome) after getting the vaccine. The reporting consumer wanted to know if there were reports of GBS and also wanted to know if she could speak to someone about GBS reports. The reporting consumer mentioned that she knew 6 people who developed GBS after getting the vaccine. Outcome of the event was unknown. This report was assessed by the reporting consumer as non-serious.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : -PFIZER INC-202101332906 same reporter/drug/event, different patients
Approximately 8 days after I received vaccine, I began have swelling, itchy sore gums. Gum bleeding. Also, had swelling and pain on the back portion of my tongue. I systematically removed things to try and pin point the cause of  allergic reaction. Went to doc on May 13th, she treated with steroids and oral rinse. That has resolved symptoms. 95% resolved
Notified by parent on 10/27 pm of marked swelling of upper arm along with some redness and itching, mild discomfort. No sig. pain, no fever, no induration. (Swelling had started same day as vaccine).
shortness of breath; Runny nose; Decongestion; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSPNOEA (non-serious), outcome "unknown", described as "shortness of breath"; RHINORRHOEA (non-serious), outcome "unknown", described as "Runny nose"; NASAL CONGESTION (non-serious), outcome "unknown", described as "Decongestion"; FATIGUE (non-serious), outcome "unknown".  Additional information: Received the Pfizer Covid 19 Vaccine the last two years and was now (as per report) had runny nose and decongestion. Caller clarified that caller had been in the Covid 19 Vaccine setting for two years. Had an e-diary and whenever had symptoms of runny nose, fatigue, shortness of breath or anything like that reports in the diary weekly. That day or the next day a doctor from the facility calls. On Monday (unspecified), caller had a runny nose and decongestion and put that in the e-diary. The doctor called the next day, or before day (06Oct2022) or whenever it was and caller explained what was happening. Was told to come into the office that day (07Oct2022), and get nose swab. Was told that Pfizer cancelled the study and won't see the caller at the office and that the caller was sent a text and called on the phone to be advised of that. Clarified, that doctor called before day afternoon, on 06Oct2022. Nobody called or sent a message informing cancelled study and won't see caller at the office. In addition, had a clin card and the clin card puts compensation for time and travel. Caller's clin card was damaged, meaning can't get compensation which already had on the clin card. There were no new clin cards at the caller's doctor's office. Can't get a new card. Money on the clin card can't be for office today to compensate time and travel. Pfizer did not call and advise caller to not come to the office or that the study was cancelled.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient states that she felt very hot and arm was burning. She said that her arm got swollen to the size of a grapefruit.
Patient complains about muscle soreness and ache and her arm hurts when she tries to lift it above her shoulders. Patient states that she can feel where the injection site is at. Patient states that the muscle soreness is still there after a couple of weeks.
chest pain; got a little tired & took a short nap; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain) and FATIGUE (got a little tired & took a short nap) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 023C21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), LAMOTRIGINE (LAMICTAL), ZIPRASIDONE HYDROCHLORIDE (GEODON [ZIPRASIDONE HYDROCHLORIDE]), TRAZODONE, DICYCLOMINE [DICYCLOVERINE], LACTOBACILLUS ACIDOPHILUS (ACIDOPHILUS [LACTOBACILLUS ACIDOPHILUS]), PROPRANOLOL, PRIMIDONE and LORAZEPAM (ATIVAN) for an unknown indication.   On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced CHEST PAIN (chest pain) and FATIGUE (got a little tired & took a short nap). At the time of the report, CHEST PAIN (chest pain) and FATIGUE (got a little tired & took a short nap) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable.  No treatment medications were provided.
"Restless" at night - toss & turn, wake frequently. Both hands intermittently "fall asleep" during night.
After client received vaccines he became lightheaded. Client was laid down on exam table and given juice and a fruit and grain bar.  After 10 minutes client sat up at edge of table, but within 3-4 minutes began to feel dizzy, became very pale and stated that his hands were tingling and his heart was racing.  Client was laid back down on exam table and given 5L of O2 per non re-breather mask.  Vital signs were taken.  After 10 minutes O2 was removed and client sat up and was given more juice and crackers.  Client stated that he felt better after sitting for 5 minutes and was release to go home.
Patient admitted 9/5 for cough, congestion and shortness of breath.  Patient discharged on 9/10.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose, route and lot not reported). The pharmacist reported that a nurse might have administered expired PNEUMOVAX 23. No adverse event reported. The outcome of the events was unknown. The reporter considered events to be not related to PNEUMOVAX 23. Additional information is not expected.
Follow up information received from a physician on 8/1/02 provided vaccine administration details, including vaccines administered within 4 weeks of Prevnar and lot numbers; illness at time of vaccination; and additional patient information. A physician reported that a 19 month old female with a history of asthma received her first dose of Prevnar on 12/29/00 at 4 months of age. At the time of vaccination, the child reportedly had bronchitis, with an illness onset of 12/15/00. On 3/31/02, she developed pneumococcal bacteremia and pneumococcal pneumonia. She presented to a hospital on 4/1/02 in respiratory distress. A blood culture was performed the same day; Streptococcus pneumoniae serotype 4 was isolated. She was intubated for 24 hours and remained in the intensive care unit for 2 days. She reportedly had a good outcome and was discharged on 4/9/02.
Lymphadenopathy- neck, axillae, along rib cage 4/16; sore throat, wheezing 4/19/06, Pt treated with albuterol inhaler and Prednisone 50mg daily x 5 days. Pt received vaccination to be compliant with current work guidelines after mumps epidemic.
Hives and itchiness on both hands and arms. Hives and itchiness on both feet and legs. Took Benadryl as directed on packaging. Hives lasted for 3 days and resolved completely by the 4th day. (No difficulty breathing or any other symptoms).
Flushing, itching, and hives within 20 minutes of shot administration. Roughly 4 hours after the shot face, lip, and tongue swelling, with hives spreading to chest and scalp. Roughly 8 hours after the shot throat swelling and wheezing. Facial/lip swelling and redness and hives lasted approximately 5 days. Treated at home with prescribed medications (allegra, pepcid, singulair, symbicort, albuterol). Fever ranging from 100.4 to 100.8 degrees Farenheit for 48 hours.
Metastatic colon cancer spread to liver. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID-19 vaccine.
Starting within 3 hours of initial injection, sharp, burning pain started in left deltoid, and progressively radiated downward into the left elbow, radius, and thumb. Effects have resisted anti inflammatory medication and Epsom salt soaks. Symptoms have lasted 9 days.
At 3:30 pm when I got home from work the day after my second shingles vaccine, I felt really tired and sore all of a sudden and could feel a little bit of a headache.   My ribs, arms and legs are sore. After a little while, I felt my skin getting warmer than usual, I took my temperature and it was 2 degrees warmer than my usual temperature.  I have a low fever and chills.  It is now almost 8pm and I still have these symptoms.  My husband is at the store getting me some ibuprofen, so I hope that will help me feel better.
Major, severe  swelling in LEFT arm. 1" in height burning sensation, hot to touch, unable to raise arm. Color red and purple. Swelling progressed to 24" in length. Difficulty breathing. Iced the swelling. Took Tylenol for two days. Still painful, still can't raise arm. Very swollen. Feels like waterlogged. Saw pharmacist. Saw doctor. Next appointment with Doctor Thursday.
Pt said she felt dizzy and "off" and that she needed to lie down. Brought into medical bay via wheelchair, (she was already in one) Laid down. Reported felt cold, blankets given, vitals taken and stable. Pt was shakey at times but reported she felt fine. Vitals remained stable. Shakiness subsided within 10 mins. Then pt rested comfortably for about 20 mins. sat up. VS stable. Left in her wheel chair at 11:20, felt much better.
Weakness in left leg, blod clots in lungs, severe headaches continuing  I went to emergency on February 23, 2021 where I treated for weakness in left leg and was admitted to hospital where I received treatments for a double pulmonary embolism on March 1.
Within 24 hours patient developed a very high fever (the only high one he has had in his entire life), became lethargic,  and would not feed.  More importantly, he stopped babbling and the first words we had heard disappeared.
Case number PHEH2014US024358, is an initial spontaneous report received from a nurse on 02 Dec 2014 and with a follow-up from a nurse received on 21 Jan 2015. This report refers to a 74 year old male patient. Medical history and concomitant medication were not reported. He had tolerated vaccines (no further details provided) well in the past. He was vaccinated with FLUVIRIN (batch number 14511P, expiry date: Mar 2015) into left deltoid intramuscularly at a dose of 0.5 ml on 20 Nov 2014. Nurse reported that PFS of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration. No further information was provided. Follow-up from a nurse received on 21 Jan 2015: Site of vaccination (left deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
pt fell asleep p/vax & 5 hr later was inconsolable for 15 mins; mom then administered 1 1/2 dropper of APAP & pt was relieved; mom took pt temp -t100; clinic recommended monitoring temp & administering APAP q 4 hr; 21MAY95 t103.5 MD-advil
hardness; itching in arm; rash; soreness; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (hardness), PRURITUS (itching in arm), RASH (rash), MYALGIA (soreness) and FATIGUE (fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for an unknown indication.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced INDURATION (hardness), PRURITUS (itching in arm), RASH (rash), MYALGIA (soreness) and FATIGUE (fatigue). At the time of the report, INDURATION (hardness), PRURITUS (itching in arm), RASH (rash), MYALGIA (soreness) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Had a 1st visit appointment with a physician the following morning.  She noticed my face and chest were very red with a rash. She referred me to a dermatologist.  When I got home the rash was on my entire upper body.  Shot arm was the reddest, then chest, other arm, face and back showed a deep almost bruise like rash below my neck.  Almost 2 weeks later, it is much lighter, but still there, especially on arms.
possible linked to isquemic stroke.  Patient was given TPa. Left MCA acute infart
Pt states a few hours after flu shot she was at home and got hives then had trouble breathing and went to hospital, was admitted to hospital for unknown # of days. Patients phone # is not working re follow up questions.
itchy eyes, onset was approximately 10 hours post vaccine, by the next morning my face was dry and peeling
Problems breathing/ felt like she was gasping for air for a few minutes; Heart was racing; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Problems breathing/ felt like she was gasping for air for a few minutes), PALPITATIONS (Heart was racing) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DYSPNOEA (Problems breathing/ felt like she was gasping for air for a few minutes), PALPITATIONS (Heart was racing) and CHILLS (Chills). At the time of the report, DYSPNOEA (Problems breathing/ felt like she was gasping for air for a few minutes), PALPITATIONS (Heart was racing) and CHILLS (Chills) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. The  patient had problems breathing and had to sit up.  She felt like she was gasping for air for a few minutes. The patient was batter at the time of reporting.  The patient did not take any medications.
53 year old female received Pfizer covid-19 immunization april and may 2021.  Developed full body pain after the 2nd shot after a few days and stopped menstrating with no further period since.
Information has been received from a physician via other company (2018173776), referring to a 75 year old male patient with asthma and chronic obstructive pulmonary disease (COPD). Information about medical history and concomitant therapy was unknown. On unknown dates (reported as before the age of 65), the patient was vaccinated with PNEUMOVAX 23 (2-3 vaccinations; dose, strength, route, lot# and expiration date were unknown) and he also received a booster of PNEUMOVAX 23 (dose, strength, route, lot# and expiration date were unknown) after 70 for prophylaxis. On an unknown date, the patient did not fully respond to the vaccine (no therapeutic response), and he received PREVNAR 13 within 5 months of PNEUMOVAX 23 (wrong technique in product usage process, reported as medical information potential adverse event (AE)). Titers still came back low after PREVNAR 13 (antibody test negative). The outcome of no therapeutic response and antibody test negative was unknown. The causality assessment was not provided by the reporter.
While walking to the restroom got out of bed and felt extremely dizzy. Almost fell to the ground but held on to the walls for support. I was able to make it back to the bed and lay down. I still feel scared to walk, so I'm staying in bed, for now.
pt recv vax 12AUG96 & 21AUG96 pt devel acute pain in shoulder & pectoral muscles as well as atrophy of the muscle in arm;